GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €24.18 million as of August 15, 2025. Its market cap has decreased by -27.31% in one year.

Market Cap

24.18M

Enterprise Value

40.83M

Revenue

2.63M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.16

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 24.18M, a decrease of -90.41%. That is a compound annual growth rate of -22.72%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	24.18M	-26.85%
Dec 31, 2024	33.05M	28.79%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	121.33B
Sanofi	101.87B
Sartorius Stedim Biotech	17.22B
bioMérieux	14.92B
Eurofins Scientific SE	12.00B
Ipsen	9.18B
ABIVAX Société Anonyme	4.46B
Virbac	2.77B

Market Cap Rankings